Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis (Q46636631)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2005

Language	Label	Description	Also known as
English	Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis	scientific article published in June 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

0 references

1 reference

based on heuristic

inferred from title

author name string

Beng H Chong

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

Tim A Brighton

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

Ross I Baker

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

Peter Thurlow

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

Choon H Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

ASTH DVT Study Group

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

19

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

173-181

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

https://scigraph.springernature.com/pub.10.1007/s11239-005-1848-x

0 references

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-1848-X

21 January 2018

Low-molecular-weight heparin: is small beautiful?

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-1848-X

21 January 2018

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11239-005-1848-X

21 January 2018

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin kinetics in venous thrombosis and pulmonary embolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European multicentre study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laboratory monitoring of the clinical effects of low molecular weight heparins

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of the incidence of deep-vein thrombosis within a defined urban population

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16082604

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-005-1848-X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

release_hwbggvg6tnenfh3hnviwjyqveu

1 reference

https://api.fatcat.wiki/v0/release/hwbggvg6tnenfh3hnviwjyqveu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16082604

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46636631&oldid=2123579739"